I would say that, yes, the pandemic has taken its toll on us, but the men and women of CSIS have found innovative ways to address the new and emerging threats during the pandemic.
For example, we have put outreach to Canadian biopharma companies and laboratories that are subjected to new threats because of the pandemic. These are the people developing vaccines and techniques to protect Canadians and, unfortunately, a number of hostile actors are interested in the same information.
CSIS and CSE put out, for the first time, a joint statement earlier this past year to talk about this threat. We have unfortunately seen a number of our other actors going there, but the outreach is continuing—